Costs of Illness in Cost-Effectiveness Analysis
- 1 December 1994
- journal article
- review article
- Published by Springer Nature in PharmacoEconomics
- Vol. 6 (6) , 536-552
- https://doi.org/10.2165/00019053-199406060-00007
Abstract
Summary Costs of illness are an important input in cost-effectiveness analysis (CEA). Reviews of the literature have found that many CEAs are of low technical quality and fail to take accoum of costs...Keywords
This publication has 34 references indexed in Scilit:
- Cost-effectiveness league tables: More harm than good?Social Science & Medicine, 1993
- National hospital discharge survey: annual summary, 1991.1993
- A Review of Cost-Effectiveness Analyses of Hypertension TreatmentPharmacoEconomics, 1992
- Cost-effectiveness analysis of hypertension treatment — A review of methodological issuesHealth Policy, 1991
- Cost-effectiveness of HMG-CoA reductase inhibition for primary and secondary prevention of coronary heart disease.1991
- The lifetime cost of injury.1990
- Principles of Cost-Effective Resource Allocation in Health Care organizationsInternational Journal of Technology Assessment in Health Care, 1990
- Challenges for Cost-effectiveness ResearchMedical Decision Making, 1986
- Cost-of-Illness Methodology: A Guide to Current Practices and ProceduresThe Milbank Memorial Fund Quarterly. Health and Society, 1982
- Cost-Benefit and Cost-Effectiveness Analysis in Health CareMedical Care, 1980